Reference health
Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
48/48 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 48 checked references that resolve
resolves10.1182/blood-2003-04-1018
Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma
resolves10.1002/path.2384
The Epstein–Barr virus oncoprotein, latent membrane protein‐1, reprograms germinal centre B cells towards a Hodgkin's Reed–Sternberg‐like phenotype
resolves10.1182/blood-2010-11-320481
Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders
resolves10.1073/pnas.0706017104
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
resolves10.1158/1078-0432.CCR-07-4709
AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features
resolves10.1182/blood-2007-05-085159
PD-1–PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma
resolves10.1182/blood-2010-05-282780
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
resolves10.1016/j.immuni.2007.05.016
Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell Responses
resolves10.1084/jem.20090847
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
resolves10.1038/nature04444
Restoring function in exhausted CD8 T cells during chronic viral infection
resolves10.1038/nature05115
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
resolves10.1128/JVI.02021-06
Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression
resolves10.1038/nm1482
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
resolves10.1053/j.gastro.2008.03.037
Dynamic Programmed Death 1 Expression by Virus-Specific CD8 T Cells Correlates With the Outcome of Acute Hepatitis B
resolves10.1073/pnas.192461099
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
resolves10.1002/cncr.24899
Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma
resolves10.1007/s00432-008-0364-8
B7-H1 up-regulated expression in human pancreatic carcinoma tissue associates with tumor progression
resolves10.1158/1078-0432.CCR-08-1608
Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
resolves10.1016/j.canlet.2008.03.056
Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer
resolves10.1158/1078-0432.CCR-06-2746
Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer
resolves10.1073/pnas.0611533104
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8
<sup>+</sup>
T lymphocytes are prognostic factors of human ovarian cancer
resolves10.1053/hupa.2001.29679
Inflammatory pseudotumor of lymph node and spleen: An entity biologically distinct from inflammatory myofibroblastic tumor
resolves10.1007/978-1-61779-080-5_5
Online Verification of Human Cell Line Identity by STR DNA Typing
resolves10.1093/nar/gki354
TOUCAN 2: the all-inclusive open source workbench for regulatory sequence analysis
resolves10.1128/jvi.55.3.710-720.1985
Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells
resolves10.1084/jem.20080809
Origin and pathogenesis of nodular lymphocyte–predominant Hodgkin lymphoma as revealed by global gene expression analysis
resolves10.1038/leu.2008.272
PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients
resolves10.1097/QAD.0b013e3282f4de23
Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands
resolves10.1016/j.jhep.2006.05.007
PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T cell apoptosis
resolves10.1093/emboj/16.21.6478
Epstein–Barr virus latent membrane protein‐1 triggers AP‐1 activity via the c‐Jun N‐terminal kinase cascade
resolves10.1093/emboj/18.11.3064
Latent membrane protein 1 of Epstein–Barr virus interacts with JAK3 and activates STAT proteins
resolves10.1038/nature09754
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
resolves10.1200/JCO.2010.32.8401
Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment
resolves10.1093/emboj/cdf389
Aberrantly expressed c‐Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF‐κB
resolves10.1371/journal.pone.0012926
Programmed Death-1 Expression on Epstein Barr Virus Specific CD8+ T Cells Varies by Stage of Infection, Epitope Specificity, and T-Cell Receptor Usage
resolves10.1097/01.TP.0000163288.98419.0D
Characteristic Pattern of Chromosomal Imbalances in Posttransplantation Lymphoproliferative Disorders: Correlation with Histopathological Subcategories and EBV Status
resolves10.1111/j.1365-2141.2006.06114.x
Comparative genome‐wide profiling of post‐transplant lymphoproliferative disorders and diffuse large B‐cell lymphomas
resolves10.1038/sj.onc.1209151
Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation
resolves10.1182/blood-2009-02-204842
Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma
resolves10.1182/blood-2010-06-291310
JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma
resolves10.1158/1078-0432.CCR-10-2660
Programmed Death Ligand 1 Is Expressed by Non–Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells
resolves10.1182/blood-2006-11-059451
NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma
resolves10.1038/modpathol.2010.130
Increase of programmed death-1-expressing intratumoral CD8 T cells predicts a poor prognosis for nasopharyngeal carcinoma
The 1 reference without a DOI — listed, not checked
no DOI — not checkedRole of the transcription factor AP-1 in melanoma differentiation
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1158/1078-0432.ccr-11-1942"><img src="https://citestamp.com/citestamped/10.1158/1078-0432.ccr-11-1942/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1158/1078-0432.ccr-11-1942)